SEC Form 4 · accession 0000899243-19-001213
Yarrow Bioscience, Inc. · YARW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott M Whitcup
Director
Period of report
Jan 14, 2019
Accepted (ET)
Jan 15, 2019 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566044
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $1.8343 | Jan 14, 2019 | M | 25,000 | D | Oct 10, 2016 | Feb 26, 2026 | Common Stock | 25,000 | 77,043 | D |